Tai Chi Shows Benefits for Parkinson Disease Patients
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
THURSDAY, Oct. 26, 2023 -- Tai chi training has a long-term beneficial effect on Parkinson disease (PD) disability and symptoms, according to a study published online Oct. 24 in the Journal of Neurology, Neurosurgery & Psychiatry.
Gen Li, from the Shanghai Jiao Tong University School of Medicine, and colleagues examined whether long-term tai chi training can maintain improvement in patients with PD. The analysis included patients with PD with tai chi training (143 individuals) and patients with PD without exercise (187 individuals) who were followed from baseline in 2016 to June 2021.
The researchers found that tai chi training reduced the annual changes in the deterioration of the Unified Parkinson's Disease Rating Scale and delayed the need for increasing antiparkinsonian therapies. The tai chi group had a significantly lower annual increase in the levodopa equivalent daily dosage. Additional benefits seen with tai chi training included motor symptoms, nonmotor symptoms, and complications.
"Tai chi could be applied in the long-term management of PD," the authors write. "The long-term beneficial effect on PD could prolong the time during which patients are nondisabled, resulting in a higher quality of life, a lower caregiver burden, and less drug usage."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.